It is hard to argue with the statement that if it worked, financing would be all over this.
My opinion is they have financing and structure already planned. My hunch is what they do not have is an FDA approved extraction protocol to launch INDs. This could be because of the protocol, cell viability, safety of protocol or simplicity of ultrasonic reactor.
IF... They get this ironed out and they can steamroll the market with a ton of news and forward traction and become a juggernaut stem cell company with best extraction tech.
Question is it even possible?
IMO and speculation in leui of 0 company communication,
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.